These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display. Suire CN; Nainar S; Fazio M; Kreutzer AG; Paymozd-Yazdi T; Topper CL; Thompson CR; Leissring MA PLoS One; 2018; 13(2):e0193101. PubMed ID: 29447281 [TBL] [Abstract][Full Text] [Related]
16. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme. Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952 [TBL] [Abstract][Full Text] [Related]
18. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme. Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395 [TBL] [Abstract][Full Text] [Related]
19. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. Fernández-Gamba A; Leal MC; Morelli L; Castaño EM Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417 [TBL] [Abstract][Full Text] [Related]